Immuneering Corp - ESG Rating & Company Profile powered by AI
The webpage contains a free Environmental, Social and Governance report for Immuneering Corp. Comprehensive ESG assessment of Immuneering Corp can be reached by signing up for free. This report of Immuneering Corp was prepared by All Street Sevva using leading machine learning.
Immuneering Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 3.2, social score of 4.8 and governance score of 8.0.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | Immuneering Corp | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Immuneering Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Immuneering Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Immuneering Corp report the average age of the workforce?
Sign up for free to unlockDoes Immuneering Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Immuneering Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Immuneering Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Immuneering Corp offer flexible work?
Sign up for free to unlockDoes Immuneering Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Immuneering Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Immuneering Corp conduct supply chain audits?
Sign up for free to unlockDoes Immuneering Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Immuneering Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Immuneering Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Immuneering Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Immuneering Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Immuneering Corp disclose water use targets?
Sign up for free to unlockDoes Immuneering Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Immuneering Corp have a product recall in the last two years?
Sign up for free to unlockDoes Immuneering Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Immuneering Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Immuneering Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Immuneering Corp disclose parental leave metrics?
Sign up for free to unlockDoes Immuneering Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Immuneering Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Immuneering Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Immuneering Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Immuneering Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Immuneering Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Immuneering Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Immuneering Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Immuneering Corp disclose its waste policy?
Sign up for free to unlockDoes Immuneering Corp report according to TCFD requirements?
Sign up for free to unlockDoes Immuneering Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Immuneering Corp disclose energy use targets?
Sign up for free to unlockDoes Immuneering Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Immuneering Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Immuneering Corp
These potential risks are based on the size, segment and geographies of the company.
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.